interleukin-1beta (163-171) has been researched along with homocysteine in 1 studies
| Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) | Studies (homocysteine) | Trials (homocysteine) | Recent Studies (post-2010) (homocysteine) |
|---|---|---|---|---|---|
| 192 | 3 | 74 | 15,871 | 1,348 | 5,010 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiNicolantonio, JJ; McCarty, MF; O'Keefe, JH | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and homocysteine
| Article | Year |
|---|---|
Interleukin-1beta may act on hepatocytes to boost plasma homocysteine - The increased cardiovascular risk associated with elevated homocysteine may be mediated by this cytokine.
Topics: Animals; Coronary Artery Disease; Evidence-Based Medicine; Homocysteine; Humans; Immunologic Factors; Inflammation Mediators; Interleukin-1beta; Models, Cardiovascular; Models, Immunological; Peptide Fragments | 2017 |